We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688249:SSENexchip Semiconductor Corp. Class A Analysis

Data as of 2026-06-01 - not real-time

CN¥42.43

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Price action: Nexchip trades at CNY 42.43, comfortably above its 20‑day (CNY 39.36), 50‑day (CNY 33.46) and 200‑day (CNY 33.96) moving averages, and the MACD is bullish (line 3.18 > signal 2.85). The RSI sits at 58.96, suggesting modest upside momentum but no overbought condition. Valuation pressure: The trailing P/E of 132.6 dwarfs the industry average of 42.3 and the DCF‑derived fair value of CNY 25.60, indicating the stock is significantly overvalued. Dividend yield is a meager 0.22% and free cash flow is deeply negative (‑CNY 6.3 bn), raising doubts about dividend sustainability. Financial health: Debt‑to‑equity stands at 71.8% with total debt (CNY 21.36 bn) far exceeding cash (CNY 4.27 bn), while ROE is only 1.46% and operating margins sit at 8%, reflecting weak profitability despite a 13.4% revenue growth rate.
Risk factors are amplified by a 30‑day volatility of 73.6% and the company’s exposure to Chinese regulatory and geopolitical headwinds. Although beta is low (0.48), the combination of high leverage, negative cash flow, and an extreme “Greed” market sentiment (Fear & Greed Index 92.6) suggests caution. The stock sits below its near‑term resistance of CNY 48.99 but above a solid support at CNY 31.51, leaving limited upside potential while the fundamentals remain fragile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup (price above SMAs, bullish MACD)
  • Significant valuation gap to DCF fair value
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 13.4% versus weak margins
  • Elevated debt levels and negative free cash flow
  • Persistently high P/E relative to industry

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Unsustainable dividend given cash flow constraints
  • Heavy leverage and low profitability
  • Structural sector and regulatory headwinds in China

Key Metrics & Analysis

Financial Health

Revenue Growth13.40%
Profit Margin5.52%
P/E Ratio132.6
ROE1.46%
ROA0.74%
Debt/Equity71.76
P/B Ratio3.8
Op. Cash FlowCN¥4.2B
Free Cash FlowCN¥-6306312192
Industry P/E42.3

Technical Analysis

TrendNeutral
RSI59.0
SupportCN¥31.51
ResistanceCN¥48.99
MA 20CN¥39.36
MA 50CN¥33.46
MA 200CN¥33.96
MACDBullish
VolumeStable
Fear & Greed Index92.59

Valuation

Fair ValueCN¥25.60
GradeOvervalued
TypeBlend
Dividend Yield0.22%

Risk Assessment

Beta0.48
Volatility73.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.